Maternal diet modulates the risk for neural tube defects in a mouse model of diabetic pregnancy

Reproductive Toxicology

Volumn 31, Issue 1, 2011, Pages 41-49

  Kappen, Claudia ^a   Kruger, Claudia ^a   MacGowan, Jacalyn ^a   Salbaum, J Michael ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Diabetes; Fat content; Folic acid; Modifier; NTD; Nutrition; Protein content; Rodent diet

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FETUS RISK; FOOD COMPOSITION; HIGH RISK PREGNANCY; INBRED STRAIN; MATERNAL DIABETES MELLITUS; MATERNAL NUTRITION; MORPHOMETRICS; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; NUTRIENT CONTENT; PREGNANCY OUTCOME; STREPTOZOCIN DIABETES;

ANIMAL FEED; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; EFFECT MODIFIERS (EPIDEMIOLOGY); EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; FEMALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICE; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY IN DIABETICS; RISK;

RODENTIA;

EID: 79551611537     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.09.002     Document Type: Article

References (69)

1. Metzger B.E., Lowe L.P., Dyer A.R., Trimble E.R., Chaovarindr U., Coustan D.R., et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008, 358:1991-2002.
2. Buchanan T.A., Kitzmiller J.L. Metabolic interactions of diabetes and pregnancy. Annu Rev Med 1994, 45:245-260.
3. Goto M.P., Goldman A.S. Diabetic embryopathy. Curr Opin Pediatr 1994, 6:486-491.
4. Sadler T.W., Hunter ESd, Wynn R.E., Phillips L.S. Evidence for multifactorial origin of diabetes-induced embryopathies. Diabetes 1989, 38:70-74.
5. Mills J.L. Malformations in infants of diabetic mothers. Teratology 1982, 25:385-394.
6. Martinez-Frias M.L. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 1994, 51:108-113.
7. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 1971, 7:73-82.
8. Chang T.I., Loeken M.R. Genotoxicity and diabetic embryopathy: impaired expression of developmental control genes as a cause of defective morphogenesis. Semin Reprod Endocrinol 1999, 17:153-165.
9. Pavlinkova G., Salbaum J.M., Kappen C. Maternal diabetes alters transcriptional programs in the developing embryo. BMC Genom 2009, 10:274.
10. Jiang B., Kumar S.D., Loh W.T., Manikandan J., Ling E.A., Tay S.S., et al. Global gene expression analysis of cranial neural tubes in embryos of diabetic mice. J Neurosci Res 2008, 86:3481-3493.
11. Reece E.A., Ji I., Wu Y.K., Zhao Z. Characterization of differential gene expression profiles in diabetic embryopathy using DNA microarray analysis. Am J Obstet Gynecol 2006, 195:1075-1080.
12. Pavlinkova G., Salbaum J.M., Kappen C. Wnt signaling in caudal dysgenesis and diabetic embryopathy. Birth Defects Res A: Clin Mol Teratol 2008, 82:710-719.
13. Gareskog M., Wentzel P. N-Acetylcysteine and alpha-cyano-4-hydroxycinnamic acid alter protein kinase C (PKC)-delta and PKC-zeta and diminish dysmorphogenesis in rat embryos cultured with high glucose in vitro. J Endocrinol 2007, 192:207-214.
14. Hiramatsu Y., Sekiguchi N., Hayashi M., Isshiki K., Yokota T., King G.L., et al. Diacylglycerol production and protein kinase C activity are increased in a mouse model of diabetic embryopathy. Diabetes 2002, 51:2804-2810.
15. Phelan S.A., Ito M., Loeken M.R. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 1997, 46:1189-1197.
16. Pani L., Horal M., Loeken M.R. Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3-dependent development and tumorigenesis. Genes Dev 2002, 16:676-680.
17. Li R., Chase M., Jung S.K., Smith P.J., Loeken M.R. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab 2005, 289:E591-599.
18. Sakamaki H., Akazawa S., Ishibashi M., Izumino K., Takino H., Yamasaki H., et al. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 1999, 48:1138-1144.
19. Wentzel P., Welsh N., Eriksson U.J. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. Diabetes 1999, 48:813-820.
20. Cederberg J., Siman C.M., Eriksson U.J. Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res 2001, 49:755-762.
21. Gareskog M., Eriksson U.J., Wentzel P. Combined supplementation of folic acid and vitamin E diminishes diabetes-induced embryotoxicity in rats. Birth Defects Res A: Clin Mol Teratol 2006, 76:483-490.
22. Siman C.M., Eriksson U.J. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes 1997, 46:1054-1061.
23. Siman C.M., Gittenberger-De Groot A.C., Wisse B., Eriksson U.J. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology 2000, 61:355-367.
24. Wiznitzer A., Ayalon N., Hershkovitz R., Khamaisi M., Reece E.A., Trischler H., et al. Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes. Am J Obstet Gynecol 1999, 180:188-193.
25. Goldman A.S., Baker L., Piddington R., Marx B., Herold R., Egler J. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci U S A 1985, 82:8227-8231.
26. Reece E.A., Wu Y.K., Zhao Z., Dhanasekaran D. Dietary vitamin and lipid therapy rescues aberrant signaling and apoptosis and prevents hyperglycemia-induced diabetic embryopathy in rats. Am J Obstet Gynecol 2006, 194:580-585.
27. Reece E.A., Wu Y.K. Prevention of diabetic embryopathy in offspring of diabetic rats with use of a cocktail of deficient substrates and an antioxidant. Am J Obstet Gynecol 1997, 176:790-797.
28. Chang T.I., Horal M., Jain S.K., Wang F., Patel R., Loeken M.R. Oxidant regulation of gene expression and neural tube development: insights gained from diabetic pregnancy on molecular causes of neural tube defects. Diabetologia 2003, 46:538-545.
29. Wentzel P., Gareskog M., Eriksson U.J. Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes 2005, 54:546-553.
30. Oyama K., Sugimura Y., Murase T., Uchida A., Hayasaka S., Oiso Y., et al. Folic acid prevents congenital malformations in the offspring of diabetic mice. Endocr J 2009, 56:29-37.
31. Zabihi S., Eriksson U.J., Wentzel P. Folic acid supplementation affects ROS scavenging enzymes, enhances Vegf-A, and diminishes apoptotic state in yolk sacs of embryos of diabetic rats. Reprod Toxicol 2007, 23:486-498.
32. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327:1832-1835.
33. Green N.S. Folic acid supplementation and prevention of birth defects. J Nutr 2002, 132:2356S-2360S.
34. Kaplan J.S., Iqbal S., England B.G., Zawacki C.M., Herman W.H. Is pregnancy in diabetic women associated with folate deficiency?. Diabetes Care 1999, 22:1017-1021.
35. Lemos M.C., Harding B., Reed A.A., Jeyabalan J., Walls G.V., Bowl M.R., et al. Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers. J Endocrinol 2009, 203:133-142.
36. Pani L., Horal M., Loeken M.R. Polymorphic susceptibility to the molecular causes of neural tube defects during diabetic embryopathy. Diabetes 2002, 51:2871-2874.
37. Embury S., Seller M.J., Adinolfi M., Polani P.E. Neural tube defects in curly-tail mice. I. Incidence, expression and similarity to the human condition. Proc R Soc Lond B: Biol Sci 1979, 206:85-94.
38. Cole W.A., Trasler D.G. Gene-teratogen interaction in insulin-induced mouse exencephaly. Teratology 1980, 22:125-139.
39. Finnell R.H., Chernoff G.F. Genetic background: the elusive component in the fetal hydantoin syndrome. Am J Med Genet 1984, 19:459-462.
40. Finnell R.H., Moon S.P., Abbott L.C., Golden J.A., Chernoff G.F. Strain differences in heat-induced neural tube defects in mice. Teratology 1986, 33:247-252.
41. Juriloff D.M., Macdonald K.B., Harris M.J. Genetic analysis of the cause of exencephaly in the SELH/Bc mouse stock. Teratology 1989, 40:395-405.
42. Macdonald K.B., Juriloff D.M., Harris M.J. Developmental study of neural tube closure in a mouse stock with a high incidence of exencephaly. Teratology 1989, 39:195-213.
43. van Straaten H.W., Copp A.J. Curly tail: a 50-year history of the mouse spina bifida model. Anat Embryol (Berl) 2001, 203:225-237.
44. Letts V.A., Schork N.J., Copp A.J., Bernfield M., Frankel W.N. A curly-tail modifier locus, mct1, on mouse chromosome 17. Genomics 1995, 29:719-724.
45. Beck S.L. Contributions of dam and conceptus to differences in sensitivity to valproic acid among C57 black and SWV mice. Reprod Toxicol 1999, 13:353-360.
46. Burren K.A., Scott J.M., Copp A.J., Greene N.D. The genetic background of the curly tail strain confers susceptibility to folate-deficiency-induced exencephaly. Birth Defects Res A: Clin Mol Teratol 2010, 88:76-83.
47. Gunn T.M., Juriloff D.M., Harris M.J. Further genetic studies of the cause of exencephaly in SELH mice. Teratology 1992, 45:679-686.
48. Copp A.J., Crolla J.A., Brook F.A. Prevention of spinal neural tube defects in the mouse embryo by growth retardation during neurulation. Development 1988, 104:297-303.
49. Shiota K. Induction of neural tube defects and skeletal malformations in mice following brief hyperthermia in utero. Biol Neonate 1988, 53:86-97.
50. Webster W.S., Edwards M.J. Hyperthermia and the induction of neural tube defects in mice. Teratology 1984, 29:417-425.
51. Seller M.J., Perkins-Cole K.J. Hyperthermia and neural tube defects of the curly-tail mouse. J Craniofac Genet Dev Biol 1987, 7:321-330.
52. Harris M.J., Juriloff D.M. Maternal diet alters exencephaly frequency in SELH/Bc strain mouse embryos. Birth Defects Res A: Clin Mol Teratol 2005, 73:532-540.
53. Stoate K.L., Harris M.J., Juriloff D.M. Accelerated embryonic development associated with increased risk of neural tube defects induced by maternal diet in offspring of SELH/Bc mice. Birth Defects Res A: Clin Mol Teratol 2008, 82:720-727.
54. Warden C.H., Fisler J.S. Comparisons of diets used in animal models of high-fat feeding. Cell Metab 2008, 7:277.
55. Wang H., Tranguch S., Xie H., Hanley G., Das S.K., Dey S.K. Variation in commercial rodent diets induces disparate molecular and physiological changes in the mouse uterus. Proc Natl Acad Sci U S A 2005, 102:9960-9965.
56. Alexenko A.P., Mao J., Ellersieck M.R., Davis A.M., Whyte J.J., Rosenfeld C.S., et al. The contrasting effects of ad libitum and restricted feeding of a diet very high in saturated fats on sex ratio and metabolic hormones in mice. Biol Reprod 2007, 77:599-604.
57. Steele C.E., Trasler D.G., New D.A. An in vivo/in vitro evaluation of the teratogenic action of excess vitamin A. Teratology 1983, 28:209-214.
58. Tom C., Juriloff D.M., Harris M.J. Studies of the effect of retinoic acid on anterior neural tube closure in mice genetically liable to exencephaly. Teratology 1991, 43:27-40.
59. Rothman K.J., Moore L.L., Singer M.R., Nguyen U.S., Mannino S., Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med 1995, 333:1369-1373.
60. White J.C., Highland M., Kaiser M., Clagett-Dame M. Vitamin A deficiency results in the dose-dependent acquisition of anterior character and shortening of the caudal hindbrain of the rat embryo. Dev Biol 2000, 220:263-284.
61. White J.C., Highland M., Clagett-Dame M. Abnormal development of the sinuatrial venous valve and posterior hindbrain may contribute to late fetal resorption of vitamin A-deficient rat embryos. Teratology 2000, 62:374-384.
62. White J.C., Shankar V.N., Highland M., Epstein M.L., DeLuca H.F., Clagett-Dame M. Defects in embryonic hindbrain development and fetal resorption resulting from vitamin A deficiency in the rat are prevented by feeding pharmacological levels of all-trans-retinoic acid. Proc Natl Acad Sci U S A 1998, 95:13459-13464.
63. Basu T.K., Tze W.J., Leichter J. Serum vitamin A and retinol-binding protein in patients with insulin-dependent diabetes mellitus. Am J Clin Nutr 1989, 50:329-331.
64. Tuitoek P.J., Ziari S., Tsin A.T., Rajotte R.V., Suh M., Basu T.K. Streptozotocin-induced diabetes in rats is associated with impaired metabolic availability of vitamin A (retinol). Br J Nutr 1996, 75:615-622.
65. Homanics G.E., Maeda N., Traber M.G., Kayden H.J., Dehart D.B., Sulik K.K. Exencephaly and hydrocephaly in mice with targeted modification of the apolipoprotein B (Apob) gene. Teratology 1995, 51:1-10.
66. Huang L.S., Voyiaziakis E., Markenson D.F., Sokol K.A., Hayek T., Breslow J.L. apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J Clin Invest 1995, 96:2152-2161.
67. Tozawa R., Ishibashi S., Osuga J., Yagyu H., Oka T., Chen Z., et al. Embryonic lethality and defective neural tube closure in mice lacking squalene synthase. J Biol Chem 1999, 274:30843-30848.
68. Kitami T., Rubio R., O'Brien W., Quackenbush J., Nadeau J.H. Gene-environment interactions reveal a homeostatic role for cholesterol metabolism during dietary folate perturbation in mice. Physiol Genom 2008, 35:182-190.
69. Juriloff D.M., Gunn T.M., Harris M.J., Mah D.G., Wu M.K., Dewell S.L. Multifactorial genetics of exencephaly in SELH/Bc mice. Teratology 2001, 64:189-200.